Bulk Drug Manufacturing in India

Challenges

  • Meeting Demand: The burden of disease in the nation is high. Additionally, India inherited the burden of 17 per cent of maternal, perinatal, and childhood disorders as well as 8.2% of TB cases, 2.8% of TB cases, and 2.1% of HIV/AIDS cases. This opens up a sizable local market for pharmaceutical companies.
  • The main problem facing the Indian pharmaceutical and API industries is meeting the rising demand from this sizable patient population.
  • Exports: Pharmaceuticals have a sizable domestic and international market, but the business faces various obstacles to boosting production and export.
  • They have to do with laws, both ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy September 2023 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Economic Development